Ocular Therapeutix, Inc. Profile Avatar - Palmy Investing

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets R…

Biotechnology
US, Bedford [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ocular Therapeutix, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of OCUL's Analysis
CIK: 1393434 CUSIP: 67576A100 ISIN: US67576A1007 LEI: - UEI: -
Secondary Listings
OCUL has no secondary listings inside our databases.